These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10474256)

  • 1. Uptake and intracellular distribution of oligonucleotides vectorized by a PAMAM dendrimer.
    Hélin V; Gottikh M; Mishal Z; Subra F; Malvy C; Lavignon M
    Nucleosides Nucleotides; 1999; 18(6-7):1721-2. PubMed ID: 10474256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle-dependent distribution and specific inhibitory effect of vectorized antisense oligonucleotides in cell culture.
    Hélin V; Gottikh M; Mishal Z; Subra F; Malvy C; Lavignon M
    Biochem Pharmacol; 1999 Jul; 58(1):95-107. PubMed ID: 10403523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cancer cells with biotin-dendrimer conjugates.
    Yang W; Cheng Y; Xu T; Wang X; Wen LP
    Eur J Med Chem; 2009 Feb; 44(2):862-8. PubMed ID: 18550227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides.
    Kang H; DeLong R; Fisher MH; Juliano RL
    Pharm Res; 2005 Dec; 22(12):2099-106. PubMed ID: 16184444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport of dendrimer nanocarriers through epithelial cells via the transcellular route.
    Jevprasesphant R; Penny J; Attwood D; D'Emanuele A
    J Control Release; 2004 Jun; 97(2):259-67. PubMed ID: 15196753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
    Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
    J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of 99mTc(CO)₃-dendrimer-FITC for cancer imaging.
    Tassano MR; Audicio PF; Gambini JP; Fernandez M; Damian JP; Moreno M; Chabalgoity JA; Alonso O; Benech JC; Cabral P
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5598-601. PubMed ID: 21778055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization.
    Saovapakhiran A; D'Emanuele A; Attwood D; Penny J
    Bioconjug Chem; 2009 Apr; 20(4):693-701. PubMed ID: 19271737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimisation of dendrimer-mediated gene transfer by anionic oligomers.
    Maksimenko AV; Mandrouguine V; Gottikh MB; Bertrand JR; Majoral JP; Malvy C
    J Gene Med; 2003 Jan; 5(1):61-71. PubMed ID: 12516052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells.
    Seib FP; Jones AT; Duncan R
    J Control Release; 2007 Feb; 117(3):291-300. PubMed ID: 17210200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers.
    Iacobazzi RM; Porcelli L; Lopedota AA; Laquintana V; Lopalco A; Cutrignelli A; Altamura E; Di Fonte R; Azzariti A; Franco M; Denora N
    Int J Pharm; 2017 Aug; 528(1-2):485-497. PubMed ID: 28624661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hairpin, dumbbell, and single-stranded phosphodiester oligonucleotides exhibit identical uptake in T lymphocyte cell lines.
    Aguilar L; Hémar A; Dautry-Varsat A; Blumenfeld M
    Antisense Nucleic Acid Drug Dev; 1996; 6(3):157-63. PubMed ID: 8915499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
    Majoros IJ; Myc A; Thomas T; Mehta CB; Baker JR
    Biomacromolecules; 2006 Feb; 7(2):572-9. PubMed ID: 16471932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers.
    Yoo H; Juliano RL
    Nucleic Acids Res; 2000 Nov; 28(21):4225-31. PubMed ID: 11058121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient introduction of macromolecules and oligonucleotides into brain capillary endothelial cells using HVJ-liposomes.
    Matsuo H; Okamura T; Chen J; Takanaga H; Ohtani H; Kaneda Y; Naito M; Tsuruo T; Sawada Y
    J Drug Target; 2000; 8(4):207-16. PubMed ID: 11144231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of head size in head-tail-type polycations on their in vitro performances as nonviral gene vectors.
    Harada A; Kawamura M; Kimura Y; Takahashi T; Kojima C; Kono K
    Macromol Biosci; 2009 Jun; 9(6):605-12. PubMed ID: 19156689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
    Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
    Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipophilic pro-oligonucleotides are rapidly and efficiently internalized in HeLa cells.
    Vivès E; Dell'Aquila C; Bologna JC; Morvan F; Rayner B; Imbach JL
    Nucleic Acids Res; 1999 Oct; 27(20):4071-6. PubMed ID: 10497272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting.
    Choi Y; Thomas T; Kotlyar A; Islam MT; Baker JR
    Chem Biol; 2005 Jan; 12(1):35-43. PubMed ID: 15664513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.